This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Gajendra Singh Chowan: Innovator in Pharmaceutical Formulations
Introduction
Gajendra Singh Chowan is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in enhancing the performance of amorphous solid and solubilized formulations. His work aims to achieve therapeutic plasma concentrations, which is crucial for effective medication delivery.
Latest Patents
Gajendra Singh Chowan holds 1 patent for his invention titled "Enhanced performance of amorphous solid and solubilized formulations for achieving therapeutic plasma concentrations." This invention focuses on solid amorphous Compound (I) and its formulations, which include solid amorphous dispersions and solution formulations. These formulations are designed to exhibit enhanced stability and bioavailability, making them valuable in therapeutic applications.
Career Highlights
Chowan is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development in the area of pharmaceutical formulations, where he applies his expertise to create innovative solutions for drug delivery.
Collaborations
Throughout his career, Gajendra has collaborated with esteemed colleagues, including Kevin J Stefanski and Sharmistha Pal. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.
Conclusion
Gajendra Singh Chowan's work in enhancing pharmaceutical formulations demonstrates his commitment to innovation in the field. His contributions are essential for improving drug stability and bioavailability, ultimately benefiting patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
